Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features

Journal of Pediatric Hematology/Oncology

Volumn 29, Issue 12, 2007, Pages 836-838

  Watanabe, Nobuhiro ^a   Yoshimi, Ayami ^b   Kamachi, Yoshiro ^c   Kawabe, Takashi ^d   Muramatsu, Hideki ^c   Matsumoto, Kimikazu ^a   Manabe, Atsushi ^e   Kojima, Seiji ^c   Kato, Koji ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Kasugai Municipal Hospital   (Japan)

^e ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

Author keywords

Differential diagnosis; Juvenile myelomonocytic leukemia; Male infants; Wiskott Aldrich syndrome

Indexed keywords

WISKOTT ALDRICH SYNDROME PROTEIN;

ARTICLE; BONE MARROW; CASE REPORT; DIFFERENTIAL DIAGNOSIS; GENE MUTATION; GRANULOCYTE; HEPATOMEGALY; HUMAN; INFANT; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKOCYTOSIS; MALE; MONOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME;

DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT, NEWBORN; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 37349020067     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181580ec5     Document Type: Article

References (20)

1. Sullivan KE, Mullen CA, Blaese RM, et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125:876-885.
2. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78:635-644.
3. Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet. 2001;27:313-317.
4. Ancliff PJ, Blundell MP, Cory GO, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood. 2006;108:2182-2189.
5. Emanuel PD. Juvenile myelomonocytic leukemia. Curr Hematol Rep. 2004;3:203-209.
6. Niemeyer CM, Arico M, Basso G, et al. Chronic myelomonocytic leukemia in childhood: a report of 110 cases. Blood. 1997;89:3534-3543.
7. Niemeyer CM, Fenu S, Hasle H, et al. Differentiating juvenile myelomonocytic leukemia from infectious disease (letter). Blood. 1998;91:365-367.
8. Tartaglia M, Niemeyer CM, Song X, et al. Somatic PTPN11 mutations in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003;34:148-150.
9. Flotho C, Valcamonica S, Mach-Pascula S, et al. Ras mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia. 1999;13:32-37.
10. Le DT, Kong N, Zhu Y, et al. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood. 2004;103:4243-4250.
11. Yamamoto T, Isomura M, Xu Y, et al. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia. Leuk Res. 2006;30:1085-1089.
12. Yamada M, Ariga T, Kawamura N, et al. Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells. J Immunol. 2000;165:1119-1122.
13. Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456-464.
14. Kajiwara M, Nonoyama S, Eguchi M, et al. WASP is involved in proliferation and differentiation of human haemopoietic progenitors in vitro. Br J Haematol. 1999;107:254-262.
15. Burns S, Cory GO, Vainchenker W, et al. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004;104:3454-3462.
16. Manabe A, Yoshimasu T, Ebihara Y, et al. Viral infections in juvenile myelomonocytic leukemia: prevalence and clinical implications. J Pediatr Hematol Oncol. 2004;26:636-641.
17. Kirby MA, Weitzman S, Freedman MH. Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection. Am J Pediatr Hematol Oncol. 1990;12:292-296.
18. Herrod HG, Dow LW, Sullivan JL. Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studies. Blood. 1983;61:1098-1104.
19. Yetgin S, Cetin M, Yenicesu I, et al. Acute parvovirus B19 infection mimicking juvenile myelomonocytic leukemia. Eur J Haematol. 2000;65:276-278.
20. Kuijpers TW, van Bruggen R, Kamerbeek N, et al. Natural history and early diagnosis of LAD-1/variant syndrome. Blood. 2007;109:3529-3537.